Clinical Leader reports AI amplifies capabilities but also risks in clinical research.
The Story
The piece highlights the legal consequences of integrating AI into these sensitive processes.
Why It Matters
This isn't just for pharma companies. For a European law firm, understanding the legal consequences of AI in regulated fields like clinical research is critical. Your clients in life sciences will face new compliance burdens, particularly with the EU AI Act approaching. You must be prepared to advise on data governance, liability, and intellectual property when AI touches sensitive research data.
What To Do About It
Review your firm's current client agreements for AI-related liability clauses, especially for life sciences or healthcare clients. Ask your team if they know where AI tools are being used, even experimentally, within client projects. If you need a framework for assessing these risks, let's talk.
